Medpace Holdings, Inc. (MEDP)

Medpace Holdings Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	451.12	404.39	282.81	245.37	181.85
Depreciation & Amortization	28.12	29.25	26.33	22.34	21.12
Stock-Based Compensation	34.79	25.51	20.52	21.41	14.47
Other Adjustments	102.91	-7.52	-2.77	-7.13	-20.82
Change in Receivables	-106.22	2.24	-48.28	-66.92	-24.98
Changes in Accounts Payable	2.63	-2.97	1.05	6.43	1.87
Changes in Accrued Expenses	97.08	16.88	82.08	52.48	26.16
Changes in Unearned Revenue	143.81	150.73	97.13	118.09	88.98
Changes in Other Operating Activities	-41.02	-9.7	-25.49	-4.02	-25.31
Operating Cash Flow	713.22	608.82	433.37	388.05	263.33
Operating Cash Flow Growth	17.15%	40.48%	11.68%	47.36%	1.80%
Capital Expenditures	-31.36	-36.55	-36.65	-36.88	-28.27
Other Investing Activities	0.22	8.24	2.02	-1.86	-3.09
Investing Cash Flow	-31.14	-28.31	-34.63	-38.74	-31.36
Short-Term Debt Issued	-	-	105	324.2	-
Short-Term Debt Repaid	-	-	-155	-274.2	-
Net Short-Term Debt Issued (Repaid)	-	-	-50	50	-
Issuance of Common Stock	57	15.86	11.38	22.07	17.64
Repurchase of Common Stock	-917.39	-169.87	-144.02	-847.85	-62.1
Net Common Stock Issued (Repurchased)	-860.39	-154.01	-132.64	-825.78	-44.45
Financing Cash Flow	-860.39	-154.01	-182.64	-775.78	-44.45
Effect of Exchange Rate Changes on Cash and Cash Equivalents	5.92	-2.51	1.08	-6.57	-3.97
Net Cash Flow	-172.39	423.99	217.18	-433.04	183.54
Free Cash Flow	681.87	572.27	396.73	351.17	235.06
Free Cash Flow Growth	19.15%	44.25%	12.97%	49.40%	3.40%
FCF Margin	26.95%	27.13%	21.04%	24.05%	20.58%
Free Cash Flow Per Share	23.09	17.88	12.46	10.43	6.24
Levered Free Cash Flow	650.38	552.03	377.26	453.81	266.39
Unlevered Free Cash Flow	644.19	527.34	428.22	400.19	263.47

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q